Distinct genomic landscapes of gastroesophageal adenocarcinoma depending on PD-L1 expression identify mutations in RAS-MAPK pathway and TP53 as potential predictors of immunotherapy efficacy.
Ann Oncol
; 32(7): 906-916, 2021 07.
Article
in En
| MEDLINE
| ID: mdl-33798656
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Adenocarcinoma
/
B7-H1 Antigen
/
Immunotherapy
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Ann Oncol
Year:
2021
Document type:
Article